NEWS

NEWS

Total 86

76
News Update Pharmaphorum highlights NeoImmuneTech
2022-12-19
75
News Update NeoImmuneTech to Present at 2023 Biotech Showcase
2022-12-15
74
Press Release New evidence of NeoImmuneTech’s NT-I7 clinical efficacy in combination with pembrolizumab in relapsed/refractory (r/r) gastrointestinal tumors
2022-11-14
73
Press Release NeoImmuneTech to Present First Data on NT-I7 (efineptakin alfa) in Combination with CAR-T tisagenlecleucel, at 2022 ASH Annual Meeting
2022-11-04
72
News Update NeoImmuneTech Joins the United Nations Global Compact
2022-10-11
71
Press Release NeoImmuneTech to Present New Advances on NT-I7 (efineptakin alfa) at 2022 SITC Annual Meeting
2022-10-06
70
Quarterly update QUARTERLY UPDATE (Q3 2022)
2022-10-04
69
Press Release NeoImmuneTech’s NT-I7 Creates a More Immunogenic Tumor Microenvironment when Associated with Pembrolizumab
2022-09-13
68
Press Release NeoImmuneTech Welcomes New Members to its Scientific Advisory Board
2022-08-08
67
News Update NeoImmuneTech to Present at Cytokine-Based Drug Development Summit
2022-07-26

1 2 3 4 5 >>>